Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: winzer5 who wrote (13870)	12/19/2004 8:37:38 PM
From: spinoza	of 14101

The CEO for Pfizer said today on one of the US networks today. He said that Celebrex will remain the market. FDA is saying they will have an announcement concerning the Cox2's in a few days. Likely Pfizer has agreed to some new more restrictive labeling in the monograph. If this is the case I would suspect it will relate to the most recent studies and could restrict celebrex to specific patient populations and/or make recommendations not to exceed specific doses. I doubt the CEO of Pfizer would be unaware of the nature of these discussions with the FDA and would make the kind of public comments today if Celebrex was about to be pulled off the market in the US or anywhere else. Stranger things have happened though. Just look at the history of DMX for example.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next